Crystallization is
one of the major challenges in using glassy
solids for technological applications. Considering pharmaceutical
drugs, maintaining a stable amorphous form is highly desirable for
improved solubility. Glasses prepared by the physical vapor deposition
technique got attention because they possess very high stability,
taking thousands of years for an ordinary glass to achieve. In this
work, we have investigated the effect of reducing film thickness on
the α-relaxation dynamics and crystallization tendency of vapor-deposited
films of celecoxib (CXB), a pharmaceutical substance. We have scrutinized
its crystallization behavior above and below the glass-transition
temperature (
T
g
). Even though vapor deposition
of CXB cannot inhibit crystallization completely, we found a significant
decrease in the crystallization rate with decreasing film thickness.
Finally, we have observed striking differences in relaxation dynamics
of vapor-deposited thin films above the
T
g
compared to spin-coated counterparts of the same thickness.